Tezuka, S., Ueno, M., Kobayashi, S., Morimoto, M., Ohkawa, S., Hirotani, A., . . . Maeda, S. (2018). Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancer. Am J Cancer Res.
Chicago Style CitationTezuka, Shun, et al. "Predictive Value of ERCC1, ERCC2, ERCC4, and Glutathione S-Transferase Pi Expression for the Efficacy and Safety of FOLFIRINOX in Patients With Unresectable Pancreatic Cancer." Am J Cancer Res 2018.
Cita MLATezuka, Shun, et al. "Predictive Value of ERCC1, ERCC2, ERCC4, and Glutathione S-Transferase Pi Expression for the Efficacy and Safety of FOLFIRINOX in Patients With Unresectable Pancreatic Cancer." Am J Cancer Res 2018.